Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 215

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Features of the dendritic cell lineage

Steinman, Ralph M., Idoyaga, Juliana·2010·Immunological Reviews

Abstract

Research on the molecular markers and functions of dendritic cell (DC) subsets is exceptionally active (1-3), explaining why it is difficult to fully cover the field even with the 21 superb reviews that follow in this volume. First, let us consider some of the nomenclature in the DC subset field (Table 1). One type of nomenclature is development oriented. Most DCs in mouse lymphoid organs in the steady state are monocyte-independent, requiring flt-3L (fms-like transcript 3 ligand) rather than M-CSF (macrophage colony-stimulating factor) for their development (4-6). In other tissues, e.g. the intestine, there are additional M-CSF dependent monocytes in the steady state (7, 8) as well as inflammatory monocytes and DCs during certain infections (9). The identification of authentic monocyte-derived DCs in vivo is an active area of research. In addition to hematopoietins like flt-3L, M-CSF, and GM-CSF (granulocyte-macrophage CSF), other pathways bear upon DC development such as the Notch/Wnt system (10). Langerhans cells (LCs) are DCs within the epidermis and other stratified squamous epithelia. They exhibit the classical features of DCs when isolated from the skin and express a lectin, Langerin/CD207, but they differ from lymphoid tissue DCs in being flt-3L independent and M-CSF dependent (7, 11). The in vivo roles of LCs have become more mysterious as a result of the development of new genetically modified mice that allow Langerin+ cells to be depleted. In effect, many functions, previously ascribed exclusively to epidermal LCs in skin, may also involve dermal Langerin+ DCs (7, 11). A second type of nomenclature distinguishes classical or conventional DCs from plasmacytoid DCs on the basis of distinct morphology, markers and gene expression profiles (12-15). Although popular, the adjectives ‘classical’ and ‘conventional’ are a little odd. They are not used in any other lineage when new forms are uncovered, e.g. immunologists do not speak of classical or conventional B cells to distinguish them from B1 and B2 pathways, and classical or conventional T cells to distinguish them from NKT and γδ T. The term ‘myeloid’ DC is often used as a counterpart to plasmacytoid DCs, although the latter are formally myeloid in origin. Plasmacytoid DCs were first identified in humans; their name indicates that they share cytologic features with plasma cells. These DCs are the long mysterious, type I interferon-producing cells (12, 13). While all DCs can produce large amounts of type I interferons, plasmacytoid DCs are able to do so upon exposure to both live and inactivated viruses, as well as self nucleic acids, e.g. the DNA from inactivated herpes viruses and self-DNA, when the latter is complexed to cationic self-peptides to enhance DNA uptake. This is because plasmacytoid DCs express Toll-like receptor 7 (TLR7) and TLR9 in an endosomal location, to recognize and respond to nucleic acids. Human DC subsets are now being distinguished with markers that are not expressed in mice, e.g. the BDCA-2 marker for plasmacytoid DCs is not found in mice, and likewise for the BDCA-1 (CD1c), BDCA-3, CD1a, CD1b markers for human DC subsets (14, 15). Although many of the markers in use are not shared between human blood and mouse lymphoid tissue DCs, there are some shared markers like DEC-205/CD205 and Langerin/CD207. Human DC subsets are relevant to disease. In histiocytosis X, LCs expand to form granulomas or rarely a more diffuse proliferative order (16). Different DC subsets are being explored to vaccinate patients, so that distinct forms of antibody and T-cell-mediated immunity can be induced (15). Another nomenclature distinction involves resident versus migratory DCs. ‘Resident DCs’ move directly to lymphoid tissues from a blood precursor, while ‘migratory DCs’ are also bone marrow-derived, but first enter tissues prior to migration via lymphatics to lymph nodes (4, 7, 8, 17-20). Nevertheless, mouse lymphoid and non-lymphoid organs can contain similar DC subsets, e.g. a CD103+ subset is found in both locations and is effective in cross presenting antigens on major histocompatibility complex class I (MHC I) products. The identification and properties of DCs at body surfaces continues to be a critical area of immunology and is valuably addressed by many of the articles that follow, e.g. DCs in the lung (20), eye (21), intestine (7, 8, 17, 18, 22), and skin (7, 11). The existence of DC subsets broadens the scope of DC biology, and figuring them out is of major interest and importance. DC subsets can have distinct roles in controlling the type of immune response (23), and each subset expresses distinct pattern recognition receptors for recognition of microbes and other antigens (24). The fact that many of the markers used to define DC subsets are involved in innate immunity (antigen uptake and presentation, DC signaling) suggests that a major raison d’être for subsets is to provide distinct innate defenses, e.g. production of pathogen-rele

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.0105-2896.2009.00888.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 215

Metadata

Authors
Steinman, R. M., & Idoyaga, J.
Venue
Immunological Reviews
Publisher
Wiley
Published
2010-02-22
Volume
234
Issue
1
Pages
5-17
ISSN
  • 0105-2896 (ISSN-L)
  • 1600-065X
OpenAlex
W1991011546
Cited by
215
References
10
FWCI
1.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Features of the dendritic cell lineage. https://app.cochat.ai/papers/10.1111/j.0105-2896.2009.00888.x
The paper
Steinman, R. M., & Idoyaga, J. (2010). Features of the dendritic cell lineage. Immunological Reviews. https://doi.org/10.1111/j.0105-2896.2009.00888.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.